Business
Opko Health (NYSE: OPK; TASE: OPK), controlled by chairman Dr. Phillip Frost, has acquired EirGen Pharma, Ltd., a pharmaceutical company based in Ireland, focused on...
Hi, what are you looking for?
Opko Health (NYSE: OPK; TASE: OPK), controlled by chairman Dr. Phillip Frost, has acquired EirGen Pharma, Ltd., a pharmaceutical company based in Ireland, focused on...
New OphthaliX strategy aims to combine ophthalmic medical devices and pharmaceutical products to address multi-billion dollar markets in treating ophthalmic diseases.
Mylan's filing on executive compensation reveals much higher pay than at Teva.
The study appears on line as a publication ahead of print in the prestigious medical journal Psychosomatic Medicine.
Brain scans show simple trick makes cheap plonk taste better
The invention to be presented at Agritech Israel 2015
Tamir Capital is invested in Proneuron, which successfully sued Teva for abuse of a license for its product.
"Although colon cancer can be classified as preventable or curable with the aid of early screening, many patients have been reluctant to undergo currently...
The US biotech company currently markets its products in Israel through NewPharm.
Teva CEO Erez Vigodman bypasses Mylan's board and appeals directly to its shareholders.